The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Talibov O.B.

Evdokimov Moscow State University of Medicine and Dentistry, Chair of Therapy, Clinical Pharmacology and Emergency Medical Care, Moscow, Russia

Pharmacology of the drugs prescribed for chronic venous diseases

Authors:

Talibov O.B.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2019;(2): 106‑109

DOI: 10.17116/hirurgia2019021106

Views: 27028

Downloaded: 552

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Talibov OB. Pharmacology of the drugs prescribed for chronic venous diseases. Pirogov Russian Journal of Surgery. 2019;(2):106‑109. (In Russ.)
https://doi.org/10.17116/hirurgia2019021106

Подписка 2025 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Close metadata
Recommended articles:
An inte­grated approach to the conservative mana­gement of patients with hemo­rrhoids. Reso­lution of the scientific and practical conference — inte­rdisciplinary expert discussion club (March 30, 2024). Russian Journal of Evidence-Based Gastroenterology. 2024;(3):67-72

The main groups of the drugs used for pharmacotherapy of chronic venous disease are considered. The main therapeutic targets of the drugs including their effect on venous wall tone, permeability and inflammation are described.

Keywords:

chronic venous disease
bioflavonoids
diosmin
rutosides
aescine
calcium dobesilate

Authors:

Talibov O.B.

Evdokimov Moscow State University of Medicine and Dentistry, Chair of Therapy, Clinical Pharmacology and Emergency Medical Care, Moscow, Russia

List of references:

  1. Russian Clinical Guidelines for the Diagnostics and Treatment of Chronic Venous Diseases. Flebologia. 2013;2(2):5-48. (In Russ.)
  2. Ibrahim S, MacPherson DR, Goldhaber SZ. Chronic venous insufficiency: mechanisms and management. Am Heart J. 1996 Oct;132(4):856-860.
  3. ATC/DDD index 2018 URL: https://www.whocc.no/atc_ddd_index/
  4. Perrin M, Ramelet AA. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. Eur J Vasc Endovasc Surg. 2011 Jan;41(1):117-125.
  5. Spanakis M, Kasmas S, Niopas I. Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic reduction of diosmetin to hesperetin. Biomed Chromatogr. 2009 Feb;23(2):124-131.
  6. Savineau JP, Marthan R. Diosmin-induced increase in sensitivity to Ca2+ of the smooth muscle contractile apparatus in the rat isolated femoral vein. British Journal of Pharmacology. 1994;111(4):978-980.
  7. First consensus meeting on veno-active agents and review of their clinical benefits. Phlebolymphology. 2005;49:384-396.
  8. Shoab SS, Porter JB, Scurr JH, Coleridge-Smith PD. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study. J Vasc Surg. 2000 Mar;31(3):456-461.
  9. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 2003;43:309-334.
  10. Domínguez C, Brautigam I, González E, González JA, Nazco J, Valiente R, Boada J. Therapeutic effects of hidrosmin on chronic venous insufficiency of the lower limbs. Curr Med Res Opin. 1992;12(10):623-630.
  11. Balant LP, Wermeille M, Griffiths LA. Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man. Q Rev Drug Metab Drug Interact. 1984;5(1):1-24.
  12. Gerdin B, Svensjö E. Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin. Int J Microcirc Clin Exp. 1983;2(1):39-46.
  13. Timeus C. The effect of oral 0-(beta-hydroxyethyl)-rutoside (HR) versus placebo on vessel wall permeability and selective permeability in the microcirculation of the skin in healthy volunteers. In: Negus D. et al. (eds). Phlebology ‘85. J Libbey & Co Ltd; London: 1986;825-827.
  14. Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W, Athanassiou A, Theoharides TC. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol. 2003 Nov 1;171(9):4830-4836.
  15. Kandere-Grzybowska K, Kempuraj D, Cao J, Cetrulo CL, Theoharides TC. Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol. 2006 May;148(2):208-215.
  16. Ivanov IS, Sidekhmenova AV, Nosarev AV, Tyukavkina NA, Plotnikov MB. Effect of dihydroquercetin on the tone of isolated rat veins. Bull Exp Biol Med. 2013 May;155(1):65-66.
  17. Mrwa U, Güth K, Haist C, Troschka M, Herrmann R, Wojciechowski R, Gagelmann M. Calcium-requirement for activation of skinned vascular smooth muscle from spontaneously hypertensive (SHRSP) and normotensive control rats. Life Sci. 1986 Jan 13;38(2):191-196.
  18. Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung. 1994 Jan;44(1):25-35.
  19. Redman DA. Ruscus aculeatus (butcher’s broom) as a potential treatment for orthostatic hypotension, with a case report. J Altern Complement Med. 2000 Dec;6(6):539-549.
  20. Nees S, Weiss DR, Reichenbach-Klinke E, Rampp F, Heilmeier B, Kanbach J, Esperester A. Protective effects of flavonoids contained in the red vine leaf on venular endothelium against the attack of activated blood components in vitro. Arzneimittelforschung. 2003;53(5):330-341.
  21. Ude C, Schubert-Zsilavecz M, Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clin Pharmacokinet. 2013 Sep;52(9):727-749.
  22. Ciapponi A, Laffaire E, Roqué M. Calcium dobesilate for chronic venous insufficiency: a systematic review. Angiology. 2004 Mar-Apr;55(2):147-154.
  23. Curtis BR. Drug-induced immune neutropenia/agranulocytosis. Immunohematology. 2014;30(2):95-101.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.